HCC and DAA Treatment in Decompensated Cirrhosis HCC and DAA Treatment in Decompensated Cirrhosis
This review explores controversies surrounding the potential impact of DAA therapy on the incidence and prognosis of hepatocellular carcinoma in patients with advanced liver disease.Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Drugs & Pharmacology | Gastroenterology | Health | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Urology & Nephrology